Stephan Probst

About

Stephan Probst is a leading figure in nuclear medicine and molecular imaging, with a primary research focus on the application of novel PET/CT tracers for oncologic staging and surgical guidance. His most cited work, a 2012 prospective study on sentinel lymph node detection in endometrial cancer (82 citations), established a critical methodological advance by demonstrating the high accuracy of intra-operative cervical injection, directly impacting surgical decision-making and reducing the need for extensive lymphadenectomy. More recently, Probst has been at the forefront of prostate-specific membrane antigen (PSMA)-targeted imaging, as evidenced by his 2023 case report on port-site metastasis identified via 18F-DCFPyL PET/CT. This work highlights an extremely rare complication following robot-assisted prostatectomy, showcasing the unparalleled sensitivity of PSMA PET/CT in detecting occult disease that eludes conventional imaging. By pushing the boundaries of molecular imaging, Probst’s research bridges the gap between diagnostic precision and therapeutic intervention, providing clinicians with powerful tools to personalize cancer care and improve patient outcomes.

Research Focus

Key Achievements

Top Papers

1. 1
   Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: A prospective study

   82 citations · 2012
2. 2
   Port-Site Metastasis Identified on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT After Robot-Assisted Laparoscopic Radical Prostatectomy

   2 citations · 2023

Key Collaborators

Contact & Links